183 related articles for article (PubMed ID: 37373272)
1. Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma.
Kamara S; Guo Y; Wen H; Liu Y; Liu L; Zheng M; Zhang J; Zhou L; Chen J; Zhu S; Zhang L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373272
[TBL] [Abstract][Full Text] [Related]
2. Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma.
Kamara S; Guo Y; Mao S; Ye X; Li Q; Zheng M; Zhu J; Zhang J; Du W; Chen J; Zhu S; Zhang L
Appl Microbiol Biotechnol; 2021 Oct; 105(19):7283-7293. PubMed ID: 34505914
[TBL] [Abstract][Full Text] [Related]
3. Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
Zhu J; Kamara S; Cen D; Tang W; Gu M; Ci X; Chen J; Wang L; Zhu S; Jiang P; Chen S; Xue X; Zhang L
Cell Death Dis; 2020 Apr; 11(4):213. PubMed ID: 32238802
[TBL] [Abstract][Full Text] [Related]
4. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
5. EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models.
Guo Y; Kamara S; Zhang J; Wen H; Zheng M; Liu Y; Zhou L; Chen J; Zhu S; Zhang L
Front Cell Infect Microbiol; 2022; 12():1078504. PubMed ID: 36683690
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
7. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
8. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
9. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
Lin MC; Lin YC; Chen ST; Young TH; Lou PJ
BMC Cancer; 2017 Jan; 17(1):18. PubMed ID: 28056887
[TBL] [Abstract][Full Text] [Related]
11. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
[TBL] [Abstract][Full Text] [Related]
12. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
13. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Lu J; Tang M; Li H; Xu Z; Weng X; Li J; Yu X; Zhao L; Liu H; Hu Y; Tan Z; Yang L; Zhong M; Zhou J; Fan J; Bode AM; Yi W; Gao J; Sun L; Cao Y
Cancer Lett; 2016 Sep; 380(1):191-200. PubMed ID: 27255972
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N
Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
17. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
[TBL] [Abstract][Full Text] [Related]
18. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.
Paramita DK; Fatmawati C; Juwana H; van Schaijk FG; Fachiroh J; Haryana SM; Middeldorp JM
J Med Virol; 2011 Apr; 83(4):665-78. PubMed ID: 21328382
[TBL] [Abstract][Full Text] [Related]
20. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
